Literature DB >> 5336967

Respiratory virus vaccines. 3. Some biological properties of Sephadex-purified ether-extracted influenza virus antigens.

F B Brandon, F Cox, G O Lease, E A Timm, E Quinn, I W McLean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5336967

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.

Authors:  H Závadová; V Vonka; E Adam; E Domorázková; F M Davenport
Journal:  Arch Gesamte Virusforsch       Date:  1972

2.  Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.

Authors:  D W Barry; E Staton; R E Mayner
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

3.  Influenza immunization: clinical studies with ether-split subunit vaccines.

Authors:  F B Brandon; F Cox; E Quinn; E A Timm; I W McLean
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults.

Authors:  D W Ortbals; H Liebhaber
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

5.  Polyethylene glycol purification of influenza virus with respect to aggregation and antigenicity.

Authors:  A Polson; A Keen; C Sinclair-Smith; I G Furminger
Journal:  J Hyg (Lond)       Date:  1972-06

6.  Automated procedure for measuring antigenicity of extracted and intact influenza virus.

Authors:  E K Hebeka; R M Walker; W B Beardmore
Journal:  Appl Microbiol       Date:  1968-11

7.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.